Trial Profile
Study for the effects of vildagliptin in combination with metformin on vascular endothelial function and systemic metabolism in patients with type 2 diabetes; multicenter, prospective, randomized, open-label, parallel group comparison
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Oct 2017
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- 15 Sep 2017 Primary endpoint (Flow-mediated dilation) has not been met as per the results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
- 15 Sep 2017 Results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
- 18 Jan 2017 Status changed from recruiting to completed.